Tyrosine kinase receptor indistinguishable from the c-met protein.
about
P1343
Interplay between scatter factor receptors and B plexins controls invasive growthA family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptorHGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell deathMolecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophy.Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activityExtracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factorThe ltk gene encodes a novel receptor-type protein tyrosine kinaseScatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptorRON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSPMET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibA splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotypeThe DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer CellsMet receptor tyrosine kinase: enhanced signaling through adapter proteinsFunctional regulation of semaphorin receptors by proprotein convertasesExpression of hepatocyte growth factor and c-met genes during hepatic differentiation and liver development in the ratDirect interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion.The tyrosine kinase receptors Ron and Sea control "scattering" and morphogenesis of liver progenitor cells in vitro.Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processingHeat-shock protein 27 (HSP27, HSPB1) is up-regulated by MET kinase inhibitors and confers resistance to MET-targeted therapy.Olive phenolics as c-Met inhibitors: (-)-Oleocanthal attenuates cell proliferation, invasiveness, and tumor growth in breast cancer modelsMet degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression.High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo.A point mutation in the MET oncogene abrogates metastasis without affecting transformation.Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors.Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer.Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapyA novel RON splice variant lacking exon 2 activates the PI3K/AKT pathway via PTEN phosphorylation in colorectal carcinoma cells.Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.The Met oncogene and basal-like breast cancer: another culprit to watch out for?Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis.Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factorc-Met modulates RPE migratory response to laser-induced retinal injury.The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth.Invasive growth: from development to metastasisMet is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis.The role of non-ras transforming genes in chemical carcinogenesisDynamic expression and localization of c-MET isoforms in the developing rat pancreas.Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection.
P2860
Q24295561-6DD4D560-DE2D-4753-8B62-F30F7E6F3269Q24318269-43C4EFAE-F464-4D9F-9589-CB6C0A38E6BAQ24324832-17CD62EB-9B7D-42B3-8F46-A1DB8ABBE6B9Q24539692-7825B85F-E997-4E21-9131-A94539C8E795Q24546366-1FB15D9A-19B9-4D5E-9EB4-4E0C4580192EQ24555664-DCCCCC92-36FB-4084-A165-540E3553BEEDQ24564727-B29EADF5-3F14-4C13-88C0-85C8B3E56912Q24564783-30F62801-3F0F-4C89-8E98-B5B4F7223375Q24594529-FABEC919-766A-43C9-A786-4A906A4C58C4Q24646295-28825E65-6C45-43D6-9BD8-59A3202CF99BQ24648317-35D03674-70E4-46BC-9B26-67AACD0AB8A0Q27313466-533DAA7C-1477-40B4-81CF-29D456AA0AAEQ28140219-66F0E6F9-6480-466F-A937-B26A9488AA65Q28203827-819F1DF2-3718-4599-B6F0-D3AF6E45D107Q28571293-FAAECE24-806E-4116-8AA5-9EBD9E427671Q30445760-8660AF70-6FD6-4E18-AF82-FBB7BF25198DQ30450983-35AD7406-F76A-4CF7-9C0A-F6A6D7D0858AQ33238614-2B8392BC-1584-4BA3-9B3B-75D51A8324FBQ33263389-B09CE523-9AE2-4F19-8939-10ED69965558Q33576236-C9FFFBCD-9007-437B-9BB7-E90D77CC31AFQ33645135-DA04C255-EC54-4FAE-883A-D1ADD1A6582BQ33654173-3ABE2D57-C9B0-4B3F-BBB5-3DDE50A2B798Q33727656-84B39173-E34C-47E6-9F0D-6D4B9B63D2B9Q33731936-A16A30B6-DFCA-4029-BBEF-BC418D7FE94DQ33769437-5A8FF62C-97A0-4228-A79A-283ED20648EBQ33779854-D66DD62D-9B80-41A8-9F42-7B800ECAD630Q33828409-A62C72FF-8E61-470E-B1B1-34DA96D71ACDQ33889099-97CE00AB-EC73-4B3A-BC89-0BFE94023D9BQ33942266-8699CDBA-9DAA-40F4-8331-8C6FDFB898A2Q33969327-F434E6E8-9350-4E8A-878D-5830FE56CA75Q34173500-054B451D-4E06-4C15-8C0A-8E8170719406Q34236194-55DEFF26-BB4B-46A5-A856-48C71301BB19Q34267718-115F649E-3E0E-4D0C-8F13-89C382C266D5Q34342411-DFDD17F5-CB3B-4976-998D-A839142216A9Q34386024-312F6847-F825-4870-BCAC-E9AD874274E1Q34584035-0517D556-E194-407A-AA9E-F8DC46AB7B4AQ34613189-06790987-A669-4376-88DB-A785D2304BF1Q35034088-5C632380-39C3-4C29-9A35-C96AD84BB2A4Q35038349-7C19974C-4A85-44BC-967D-CD99FA040C80Q35051660-ADD6D3C7-7BCF-4FB2-933F-61709AE1B3D1
P2860
Tyrosine kinase receptor indistinguishable from the c-met protein.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Tyrosine kinase receptor indistinguishable from the c-met protein.
@en
Tyrosine kinase receptor indistinguishable from the c-met protein.
@nl
type
label
Tyrosine kinase receptor indistinguishable from the c-met protein.
@en
Tyrosine kinase receptor indistinguishable from the c-met protein.
@nl
prefLabel
Tyrosine kinase receptor indistinguishable from the c-met protein.
@en
Tyrosine kinase receptor indistinguishable from the c-met protein.
@nl
P2093
P356
P1433
P1476
Tyrosine kinase receptor indistinguishable from the c-met protein.
@en
P2093
Comoglio PM
Di Renzo MF
Giordano S
Ponzetto C
P2888
P304
P356
10.1038/339155A0
P407
P4510
P577
1989-05-01T00:00:00Z
P6179
1018635692